Literature DB >> 22242737

Demographic characteristics of 161-km ultramarathon runners.

Martin D Hoffman1, Kevin Fogard.   

Abstract

Despite considerable recent growth in ultramarathon running, little is known about the characteristics of the participants. This work documents demographic characteristics of 161-km ultramarathoners. Surveys were completed by 489 of 674 runners entered in two of the largest 161-km ultramarathons in North America in 2009. Respondents had a mean (± SD) age of 44.5 ± 9.8 years (range 20-72 years) and were generally men (80.2%), married (70.1%), had bachelor's (43.6%) or graduate (37.2%) degrees, and used vitamins and/or supplements (75.3%). They reported 2.8 ± 20.2 days of work or school loss in the previous year from injury or illness. Body mass index (23.4 ± 2.2 and 20.8 ± 1.8 kg/m2 for men and women, respectively) was not associated with age. The findings indicate that 161-km ultramarathon participants are largely well-educated, middle-aged, married men who rarely miss work due to illness or injury, generally use vitamins and/or supplements, and maintain appropriate body mass with aging.

Entities:  

Mesh:

Year:  2012        PMID: 22242737     DOI: 10.1080/15438627.2012.634707

Source DB:  PubMed          Journal:  Res Sports Med        ISSN: 1543-8627            Impact factor:   4.674


  27 in total

1.  Exercise training reduces the risk of opportunistic infections after acute exercise and improves cytokine antigen recognition.

Authors:  Kyung-Wan Baek; Jin-Ok Jo; Yun-Jeong Kang; Kyoung Seob Song; Hak Sun Yu; Jung-Jun Park; Yung Hyun Choi; Hee-Jae Cha; Mee Sun Ock
Journal:  Pflugers Arch       Date:  2019-05-20       Impact factor: 3.657

2.  What is the age for the fastest ultra-marathon performance in time-limited races from 6 h to 10 days?

Authors:  Beat Knechtle; Fabio Valeri; Matthias Alexander Zingg; Thomas Rosemann; Christoph Alexander Rüst
Journal:  Age (Dordr)       Date:  2014-10-04

3.  Analysis of performance and age of the fastest 100-mile ultra-marathoners worldwide.

Authors:  Christoph Alexander Rüst; Beat Knechtle; Thomas Rosemann; Romuald Lepers
Journal:  Clinics (Sao Paulo)       Date:  2013-05       Impact factor: 2.365

4.  Increase in finishers and improvement of performance of masters runners in the Marathon des Sables.

Authors:  Saskia Carolin Jampen; Beat Knechtle; Christoph Alexander Rüst; Romuald Lepers; Thomas Rosemann
Journal:  Int J Gen Med       Date:  2013-06-05

5.  Analysis of participation and performance in athletes by age group in ultramarathons of more than 200 km in length.

Authors:  Matthias A Zingg; Beat Knechtle; Christoph A Rüst; Thomas Rosemann; Romuald Lepers
Journal:  Int J Gen Med       Date:  2013-04-09

6.  Central European triathletes dominate Double Iron ultratriathlon - analysis of participation and performance 1985-2011.

Authors:  Katrin Sigg; Beat Knechtle; Christoph Alexander Rüst; Patrizia Knechtle; Romuald Lepers; Thomas Rosemann
Journal:  Open Access J Sports Med       Date:  2012-10-29

Review 7.  Prevalence of Dietary Supplement Use by Athletes: Systematic Review and Meta-Analysis.

Authors:  Joseph J Knapik; Ryan A Steelman; Sally S Hoedebecke; Krista G Austin; Emily K Farina; Harris R Lieberman
Journal:  Sports Med       Date:  2016-01       Impact factor: 11.136

8.  Participation and performance trends in ultra-endurance running races under extreme conditions - 'Spartathlon' versus 'Badwater'.

Authors:  Kristina da Fonseca-Engelhardt; Beat Knechtle; Christoph Alexander Rüst; Patrizia Knechtle; Romuald Lepers; Thomas Rosemann
Journal:  Extrem Physiol Med       Date:  2013-05-01

9.  Master runners dominate 24-h ultramarathons worldwide-a retrospective data analysis from 1998 to 2011.

Authors:  Matthias Zingg; Christoph Alexander Rüst; Romuald Lepers; Thomas Rosemann; Beat Knechtle
Journal:  Extrem Physiol Med       Date:  2013-07-01

10.  Runners in their forties dominate ultra-marathons from 50 to 3,100 miles.

Authors:  Matthias Alexander Zingg; Christoph Alexander Rüst; Thomas Rosemann; Romuald Lepers; Beat Knechtle
Journal:  Clinics (Sao Paulo)       Date:  2014-03       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.